Press Releases

Press Releases

Actavis plc announced that it has received final approval from the U.S. Food and Drug Administration on its Abbreviated New Drug Application for a generic version of Reckitt Benckiser's Subutex® (Buprenorphine 2 mg and 8 mg sublingual tablets).  Actavis intends to begin shipping its product shortly. Subutex® is indicated for…

Press Releases

NewLink Genetics Corporation announced that it had received notification from Merck (MRK) that the milestone event specified in the license and collaboration agreement between the two companies relating to the further development of the rVSV-EBOV (Ebola) vaccine candidate had been achieved. Under the terms of the agreement, NewLink Genetics will…

Press Releases

Australian stem cell and regenerative medicine company Cynata Therapeutics (ASX: CYP) has achieved a world first breakthrough in the manufacture of stem cells and is now set to scale up manufacturing of its mesenchymal stem cells (MSCs) for therapeutic use. The Company's lead platform technology – a novel stem cell…

Press Releases

Using advanced DNA sequencing methods, an international consortium that includes scientists and clinicians from Columbia University Medical Center (CUMC), Biogen Idec (NASDAQ: BIIB) and HudsonAlpha Institute for Biotechnology has identified a new gene that is associated with sporadic amyotrophic lateral sclerosis (ALS), or Lou Gehrig’s disease. The newly associated gene,…

Press Releases

Celsis, the global leader in rapid microbial testing systems for industry, today introduced the Celsis Accel System for Pharma, a rapid microbial screening system for Pharmaceutical manufacturing companies with midrange test volumes. The Celsis Accel borrows the robustness and ease-of-use of the large capacity Celsis Advance II, packaged into a…

Press Releases

Actavis plc announced that it will adopt a new corporate name – Allergan – following the anticipated successful completion of the acquisition of Allergan, Inc. The Company said that it intends to use the Allergan name as its corporate name and for its global branded pharmaceutical portfolio, and will retain…

Press Releases

Aerie Pharmaceuticals, Inc., a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with glaucoma and other diseases of the eye, announced today potentially breakthrough findings from new preclinical research. The new research has indicated that Aerie’s lead drug candidate, RhopressaTM,…

Press Releases

Coronado Biosciences, Inc. has obtained an exclusive license to an intravenous (IV) formulation of tramadol for the U.S. market from Revogenex Ireland Ltd., a privately held company in Dublin, Ireland. Coronado has formed a wholly owned subsidiary, Avenue Therapeutics, Inc., to acquire, in-license, develop and commercialize products principally for use…

Press Releases

Three highly-experienced pharmaceutical and healthcare industry executives have formed next20, a new "Thought Partnership" which provides strategic support to help healthcare and pharmaceutical companies of all sizes identify and fully-leverage revenue opportunities. next20 is led by Managing Partners: Eric Sirota, who formerly worked as COO for Optimer Pharmaceuticals; Ian Henry,…

Press Releases

Biogen Idec Inc. announced that it will present at the 2015 RBC Capital Markets’ Global Healthcare Conference. The webcast will be live on Wednesday, February 25, 2015 at 11:00 a.m. ET. To access the live webcast, please visit Biogen Idec’s Investors section at www.biogenidec.com. An archived version of the webcast…